Drug for treating herpes simplex virus keratities

Abstract

The invention discloses a drug for treating herpes simplex virus keratities, belonging to the field of traditional Chinese medicine. The drug comprises the active ingredients in parts by weight: 34-50 parts of chrysanthemum, 30-46 parts of garden balsam, 28-44 parts of radix paeoniae rubra, 25-40 parts of dandelion, 22-36 parts of viola yedoensis, 18-32 parts of semen cuscutae, 15-28 parts of periostracum cicada, 12-25 parts of semen plantaginis, 10-22 parts of corn mint, 8-18 parts of semen cassiae, 5-15 parts of caulis akebiae and 3-12 parts of pipewort. The drug is reasonable in compatibility, and excellent to prepare, is based on clearing heat and detoxifying and dispersing wind and heat, achieves the purposes of inducing diuresis with bland drug and tonifying the liver and kidney, and pursues the effects of removing nebula aiming at the pathopoiesia factors of sthenia syndrome and fever syndrome, wind-heat exterior sthenia, spleen deficiency and damp-heat, liver and gall fire toxin and the like causing herpes simplex virus keratities, and has better curative effects on superficial stromal keratitis, deep stromal keratitis and degenerated herpes keratities.

Description

Technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a medicine for treating herpes simplex virus keratitis. Background technique [0002] Herpes simplex virus keratitis is the most serious common corneal disease at present, and it has a clear rising and aggravating trend in recent years. Due to recurrent attacks and increasing number of severe cases, it seriously threatens visual function, so strengthening the research on this disease has become an urgent problem to be solved in ophthalmology. The clinical manifestations of this disease are complicated. In addition to the typical shape of branches, maps and disc-shaped corneal lesions, there are also some atypical clinical changes, which bring great difficulties to diagnosis and treatment. Each type not only has unique clinical characteristics, but also has different pathogenesis and treatment principles. The various types of staining can be transformed into each othe...

AI Technical Summary

Problems solved by technology

[0003] At present, the clinical treatment methods for herpes simplex virus keratitis mainly include: focus debridement, suitable for superficial cases, the principle is to remove infected cells and viruses through physical or chemical methods, including mechanical debridement, chemical debridement, etc. Debridement, freezing debridement, photoinactivation therapy, debridement of the lesion can only remove infected cells but not prevent virus reproduction, may damage the corneal epithelial basement membrane and stromal layer, and promote the development of lesions to the deep, cryotherapy has no effect on the vitality of HSV Antiviral drugs, such as iodinidine, cytarabine, trifluorothymidine, etc., are mostly used in the late treatment of herpes simplex virus keratitis; corticosteroids, inhibit the release of histamine and toxic lytic enzymes, and reduce inflammation Reaction and tissue damage, reduce scar formation, promote angiogenesis, but there is also the risk of damaging the immune mechanism of the body and corneal tissue; surgical treatment, suitable for deep ulcers, stromal necrotizing keratitis combined with perforation, relying on drugs and conservative treatment alone Conditions that have been ineffective, including conjunctival flap covering, anterior chamber puncture, lamellar or penetrating keratoplasty, surgical therapy has clinical surgical risks